Trial · NCT03957720
The Individual Therapy for Patients With Wilson's Disease
NCT03957720, Early phase 1, Unknown, Second Affiliated Hospital, Zhejiang University, School of Medicine
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Individual Therapy for Patients With Wilson's Disease. Trials, record NCT03957720. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03957720
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Individual Therapy for Patients With Wilson's Disease
- NCT number
- NCT03957720
- Status
- Unknown
- Phases
- Early phase 1
- Enrollment
- 400 participants, estimated
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Conditions
- Wilson's Disease
- Interventions
- DMPS, Penicillamine, DMSA, Zinc gluconate
- First posted
- 2019-05-21
- Last updated
- 2019-05-21
Source ClinicalTrials.gov
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Serum ceruloplasmin | Five years | Serum ceruloplasmin concentration will be analysed using a validated assay |
| Primary | 24-hour urine copper | Five years | 24-hour urinary copper excretion is to be measured |
| Primary | serum copper | Five years | serum copper will be analysed using a validated assay |
| Primary | White blood cell | Five years | The white blood cell will be evaluated using a validated assay |
| Primary | Platelet count | Five years | The platelet count will be evaluated using a validated assay |
| Primary | urine protein level | Five years | The urine protein level will be collected using a validated assay |
| Primary | Alanine transaminase | Five years | The concentration of alanine transaminase will be collected using a validated assay |
| Primary | blood creatinine | Five years | The concentration of blood creatinine will be tested using a validated assay |
| Primary | international normalized ratio | Five years | The international normalized ratio will be analyzed |
| Primary | hepatic fibrosis markers test | Five years | The concentrations of procollagen III, collage IV and hyaluronidase will be evaluated using a validated assay |
1 to 10 of 15Source ClinicalTrials.gov
See all 15 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03957720
GET https://conductscience.org/api/trials/v1/NCT03957720/registered